Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia
Open Access
- 6 July 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (7) , 2305-2308
- https://doi.org/10.1002/art.20355
Abstract
Objective: To determine if antibodies to cyclic citrullinated peptide (anti‐CCP) are found in chronic hepatitis C virus (HCV) infection.Methods: Rheumatoid factor (RF) and anti‐CCP were measured in sera from 50 patients with HCV infection but without cryoglobulinemia, sera from 29 patients with mixed cryoglobulinemia (including 13 with rheumatic symptoms and 5 with arthritis), and sera from 20 normal blood donors. Anti‐CCP was measured by second‐generation enzyme‐linked immunosorbent assay (ELISA).Results: No sera with elevated anti‐CCP were found in patients with HCV infection without cryoglobulinemia, and in that population, the maximum anti‐CCP was 10 units, well below the positive cutoff of 20 units. Positive findings on RF testing >13 IU/ml were present in 22 (44%) of the HCV patients, with RF >50 IU/ml in 8 (16%) and a maximum RF of 526 IU/ml. Of the cryoglobulinemia patients, 22 (76%) had positive results on tests for RF, including 18 (62%) with RF >50 IU/ml and a maximum RF of 5,540 IU/ml. Two (6.9%) of the cryoglobulinemia patients had borderline‐positive findings on tests for anti‐CCP (25 units and 37 units), which were false‐positive results caused by nonspecific binding in the ELISA. No association between the RF and the anti‐CCP concentrations was found.Conclusion: Whereas RF was frequent in patients with HCV infection with and without cryoglobulinemia, anti‐CCP was not observed in patients with uncomplicated HCV infection. Borderline‐positive anti‐CCP results were observed infrequently in patients with mixed cryoglobulinemia and were caused by nonspecific binding to plastic. Measurement of anti‐CCP may help in diagnosing RA in patients with chronic HCV infection.Keywords
This publication has 14 references indexed in Scilit:
- Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvementArthritis Research & Therapy, 2004
- Clinical utility of the anti-CCP assay in patients with rheumatic diseasesAnnals of the Rheumatic Diseases, 2003
- Mapping the HLA association in Behçet's disease: A role for tumor necrosis factor polymorphisms?Arthritis & Rheumatism, 2003
- How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritisArthritis & Rheumatism, 2002
- Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodiesArthritis & Rheumatism, 2001
- The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of FibrinThe Journal of Immunology, 2001
- Hepatitis C–associated arthritisCurrent Opinion in Rheumatology, 2000
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.Journal of Clinical Investigation, 1998
- Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding regionJournal of General Virology, 1995
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988